Clenbuterol-Induced Myocarditis: A Case Report

  • Natassja Moriarty Department of Medicine, Furness General Hospital, Barrow-in-Furness, United Kingdom
  • Nadeem Attar Department of Cardiology, Furness General Hospital, Barrow-in-Furness, United Kingdom

Keywords

Clenbuterol, myocardial infarction

Abstract

Objective: We present a case of a 22-year-old bodybuilder diagnosed with myocarditis secondary to clenbuterol use.
Results: The patient was primarily managed conservatively by the discontinuation of clenbuterol and the temporary use of dual anti-platelets, beta-blockers and nitrates.
Conclusion: Clenbuterol is a long-acting beta-2 agonist primarily used in veterinary medicine. In recent years, it has been illegally marketed as a weight loss supplement because of its anabolic properties and is popular among fitness enthusiasts. It is our aim to use this case to underscore the adverse effects of this drug with hopes that tighter regulations will be instituted to stem its illegal distribution.

VIEW THE ENTIRE ARTICLE

References

  • Daubert G, Mabasa V, Leung V, Aaron C. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. J Med Toxicol 2007;3(2):56–60.

  • Barry A, Graham M. Case report and review of clenbuterol cardiac toxicity. J Cardiol Cases 2013;8(4):131–133.

  • Kierzkowska B, Stanczyk J, Kasprzak J. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J 2005;69(9):1144–1146.

  • Shafrir A, Leibowitz DW, Alcalai R, Elitzur Y, Muszkat M. Myocardial injury induced by the long acting beta2 adrenergic agonist clenbuterol. Cardiol Cardiovasc Med 2019;3(4):186–192.

  • Brett J, Dawson A, Brown J. Clenbuterol toxicity: a NSW Poisons Information Centre experience. Med J Aust 2014;200(4):219–221.

  • Huckins D, Lemons M. Myocardial ischemia associated with clenbuterol abuse: report of two cases. J Emerg Med 2013;44(2):444–449.

  • Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop N, et al. ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006;13(5):687–694.

  • Burniston J, Ng Y, Clark W, Colyer J, Tan L, Goldspink D. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 2002;93(5):1824–1832.
  • Published: 2020-06-24

    Issue: LATEST ONLINE (view)

    Section: Articles

    How to cite:
    Moriarty, N., & Attar, N. (2020). Clenbuterol-Induced Myocarditis: A Case Report. European Journal of Case Reports in Internal Medicine, 2. https://doi.org/https://doi.org/10.12890/2020_001662